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Abstract: Rhabdomyosarcoma (RMS) is a common soft tissue sarcoma in childhood, however, it is
very rare in the neonatal period (0.4–2% of cases). This case depicts a boy, who presented with RMS
at two weeks of age, but officially diagnosed at the age of three months. MRI and scintigraphy
determined a soft tissue tumor in the soleus muscle, while biopsy confirmed embryonal RMS with
high mitotic activity (Ki67 (monoclonal antibodies) ~80%). CWS (Cooperative Weichteilsarkom
Studiengruppe)-2012 with I2VA (ifosfamide, vincristine, actinomycin) chemotherapy regimen was
administered per protocol. Surgical treatment was performed at age of six months and 18 days.
The operation consisted of radical tumor resection and total triceps surae with partial fibula resection.
Immediate reconstruction of triceps muscle was accomplished using a vascularized functional
musculocutaneous vastus lateralis flap. Functional outcome was measured using the Lower Extremity
Functional Scale (LEFS) and the Foot and Ankle Outcome Score (FAOS) with the results of 92.5% and
99% respectively.
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1. Introduction
Pediatric soft tissue sarcomas are part of a heterogeneous group of tumors originating from
embryonic mesodermal tissues during the process of differentiation into various mesenchymal tissue
components of the human body. These tumors constitute 6% to 8% of all cancers in children less than
15 years of age [1], however, it is very rare in the neonatal period as its incidence is 0.4–2% of cases
with male predisposition [2]. Surgery remains the standard of treatment, yet the curative aim cannot
be achieved without adjuvant treatment. Pre-treatment staging and risk classification are of prime
importance in selecting an effective treatment protocol. Tumor resectability, the response to induction
chemotherapy and radiation generally determine the risk group, and these factors are functions of
tumor site, size, and biology. Surgery provides the best choice for local control of small resectable
tumors in a favorable site. Reconstructive possibilities are limited in the pediatric population younger
than two years of age due to relatively small structures such as blood vessels [3]. There are paucity
of articles showing microvascular reconstruction cases for patients at the age of four to six months.
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Well-known microvascular flaps such as the latissimus dorsi (LD) or rectus abdominis muscle flap have
been reported to close defects for pediatric patients at an infant age [4–6]. The operation is challenging
and needs to be led by experienced surgeons due to the small size of vessels and risk of vasospasms.
2. Case Report
A three-month-old boy is admitted for investigations as his left lower leg is much larger than
his right lower leg. On admission, the circumference, which measured at 4–5 centimeters (cm) below
the patella at the thickest part of the lower leg on the left side, was 23 cm while the right side was
18.5 cm. This mass was palpable at the age of two weeks and had exponential growth. He is the first
child and pregnancy to term, and was born at 41 weeks. However, during delivery he experienced
asphyxia and aspiration with an Apgar score of 3/4/6. He had a normal birthweight of 4200 g and
neonatal investigations of neurosonography, abdominal ultrasonography (USG), and echocardiogram
determined no pathologies. His mother worked in carpentry, where she had contact with chemical
compounds while pregnant.
Magnetic resonance imaging (MRI) and scintigraphy determined a soft tissue tumor in the
soleus muscle, while biopsy confirmed embryonal rhabdomyosarcoma with high mitotic activity
(Ki67 (monoclonal antibodies) ~80%) (Figures 1 and 2).
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Figure 1. Scintigraphy at three months old, revealing a soft tissue mass in the left calf. Figure 1. Scintigraphy at three months old, revealing a soft tissue mass in the left calf.
CWS (Cooperative Weichteilsarkom Studiengruppe)-2012 with I2VA (ifosfamide, vincristine,
actinomycin) chemotherapy regimen was administered per protocol after a port-a-cath was inserted.
The treatment comprises 9 courses I2VA with Ifosfamid (as three-hour infusion daily on Days 1 and 2
of each course), Vincristine (as single intravenous bolus injection on Day 1 of each course with two
additional injection on Day 1 of Week 2, 3, 5, 6) and Actinomycin-D (as single intravenous bolus
injection on Day 1 of each course) with prophylactic support of 24 h hydration with uromitexan,
intravenous (i/v) dezintoxication, ondansetron, methylprednisolone, and per os (p/o) biseptol. Interval
between the courses is three weeks. During chemotherapy, he needed erythrocyte and thrombocyte
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transfusions. He received four rounds of chemotherapy before undergoing radical surgical treatment at
the age of six months and 18 days (202 days old). On the operation day, his left lower leg circumference
was the same as that of the right lower leg—18 cm.Medicina 2020, 56, x FOR PEER REVIEW 3 of 8 
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Figure 2. Magnetic resona ce imaging (MRI) at t ree onths old. RMS (rhabdomyosarco a) mass in
the superficial posterior compartment of the left lower limb.
Operation started with a longitudinal incision of the lower leg to secure a wide opening and good
visualization for the radical tumor resection. The open biopsy skin scar, total superficial posterior
compartment and proximal section of fibula were resected to obtain radical tumor excision with at
least two centimeters margins. The gastrocnemius, plantaris and soleus muscles were resected at
the proximal level two centimeters from their origin and distally at the Achilles tendon level two
centimeters from their insertion in calcaneus. No functional muscles were left in posterior superficial
compartment. D p posterior compartm nt muscles and structures were l ft intact as the tumor
was localized at the lateral part of the triceps surae mus le. Longitudinal osteotomy of fibul with
fibular proximal growth plate was performed for the radical removal of the lateral insertion of soleus
muscle. Lateral compartment muscles and structures were preserved. The tibial nerve and posterior
tibial artery were preserved, while two gastrocnemius motor branches were dissected for functional
muscle reinnervation.
Immediate reconstruction of posterior muscle group was accomplished using a vascularized
musculocutaneous vastus lateralis flap. The ipsilateral leg was used to minimize donor site morbidity
as amputation is the next step if there is tumor rec rrence. A ten-centimeter incision was rendered in
the lateral side of femur, the fascia latae was separated and therefore, the quadriceps muscles exposed.
Vastus l teralis muscle was dissec ed at the proximal level near t great trochanter and distally at
the tendon. Two centimeters of the quadriceps tendon was included in flap for the Achilles tendon
reconstruction. ALT (anterior lateral thigh) perforator with skin paddle was also included in composite
flap. The separated fascia latae was not included in flap.
ALT perforator was rising from the vascular branch of vastus lateralis muscle and directing
through the muscle. Lateral femoral circumflex artery with two concomitant veins were dissected to
established blood supply to vastus lateralis muscle flap. Artery size was measured at 0.4–0.6 mm at the
level of dissection. Two motor branches of the vastus lateralis muscle were visualized and included in
flap for motor reinnervation. Total size of vastus muscle 8 × 4 cm with 4 × 2 cm skin perfor tor flap.
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End-to-end posterior tibial artery and two concomitant veins anastomoses were realized with 10/0
nylon sutures. Two gastrocnemius muscular nerves were used to secure reinnervation for the vastus
lateralis muscle flap. Vastus lateralis muscle was attached to the gastrocnemius muscle’s origin using
absorbable sutures and distally was sutured to Achilles tendon using absorbable sutures (Figure 3).
Donor site was realized with primary closure. The operation was completed in six hours and 40 min.
No anticoagulants were used in postoperative period. Simple rehydration using Ringer lactate was
used with targeting the hematocrit level less than 30%.
Medicina 2020, 56, x FOR PEER REVIEW 4 of 8 
 
tendon reconstruction. ALT (anterior lateral thigh) perforator with skin paddle was also included in 
composite flap. The separated fascia latae was not included in flap. 
ALT perforator was rising from the vascular branch of vastus lateralis muscle and directing 
through the muscle. Lateral femoral circumflex artery with two concomitant veins were dissected to 
established blood supply to vastus lateralis muscle flap. Artery size was measured at 0.4–0.6 mm at 
the level of dissection. Two motor branches of the vastus lateralis muscle were visualized and 
included in flap for motor reinnervation. Total size of vastus muscle 8 × 4 cm with 4 × 2 cm skin 
perforator flap. End-to-end posterior tibial artery and two concomitant veins anastomoses were 
realized with 10/0 nylon sutures. Two gastrocnemius muscul r nerves were ed to secure 
reinn rvation for the vastus lateralis muscle flap. Vas us lateralis muscle was attached to the 
gastrocnemius muscle’s origin using absorbable sutures and distally was sutured to Achilles ten on 
using absorbable sutures (Figure 3). Donor site was realized with primary closure. The operation was 
completed in six hours and 40 minutes. No anticoagulants were used in postoperative period. Simple 
rehydration using Ringer lactate was used with targeting the hematocrit level less than 30%.  
 
Figure 3. The tumor successfully resected with the tumor’s approximate size of 5 × 6 × 2 cm (A). Lower 
leg after radical tumor removal with a preserved tibial nerve (B). Functional vastus lateralis 
myocutaneous flap with ALT (anterolateral thigh) perforator based skin paddle (C). Microvascular 
flap with vascular supply after anastomoses (D). 
The histology report confirms the immunohistochemical profile of embryonal 
rhabdomyosarcoma, however, separate tumor cells constituted on one of the resected edges. 
Therefore, the tumor was removed within neoplastic tissue borders, but it did not change the 
chemotherapy or require additional radiation therapy. The patient continued postoperative 
chemotherapy with his fifth round requiring filgrastim due to neutropenia and continual antifungal 
prophylaxis (fluconazole, clotrimazole). After the seventh round of chemotherapy, a control MRI 
determined possible residual tumor tissues 2.4 × 0.8 × 2.2 cm with unclear borders that absorbs 
contrast. USG controlled puncture biopsy was performed and the histology determined cutaneous 
and subcutaneous soft tissue with fibrosis and non-specific chronic granulomatous inflammatory 
inflammation, however, there is no definite data about malignancy in this material. Removed tissues 
Figure 3. The tumor successfully resected with the tumor’s approximate size of 5 × 6 × 2 cm (A).
Lower leg after radical tumor removal with a preserved tibial nerve (B). Functional vastus lateralis
myocutaneous flap with ALT (anterolateral thigh) perforator based skin paddle (C). icrovascular flap
with v scular supply after anastomo es (D).
The histology report confirms the immunohistochemical profile of embryonal rhabdomyosarcoma,
however, separate tumor cells constituted on one of the resected edges. Therefore, the tumor
was removed within neoplastic tissue borders, but it did not change the chemotherapy or require
additional radiation therapy. The patient continued postoperative chemotherapy with his fifth
round requiring filgrastim due to neutropenia and continual antifungal prophylaxis (fluconazole,
clotrimazole). After the seventh round of chemotherapy, a control MRI determined possible residual
tumor tissues 2.4 × 0.8 × 2.2 cm with unclear borders that absorbs contrast. USG controlled puncture
biopsy was performed and the histology determined cutaneous and subcutaneous soft tissue with
fibrosis and non-specific chronic granulomatous infla matory inflam ation, however, there is no
definite data about malignancy in this material. Removed tissues were interpret as postoperative
scaring tissues associate with postoperative hematoma. In total, the patient received nine rounds of
chemotherapy. He completed treatment with port removal at the age of eight months and 23 days
(327 days old).
During the postoperative period, no tumor recurrence or metastases were observed. At the
two-year follow-up, the patient’s left side was visibly smaller than the right, however, he performed
all lower leg movements without hindrances (Figure 4). The Medical Research Council’s scale (MRC
scale) was used to evaluate muscle power of the limb. The MRC scale of posterior compartment
muscle strength for the movement of the talocrural joint scored 4–5 points as strength was little bit
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lower in comparison to the healthy side. The MRC for quadriceps muscle for the movement of knee
joint scored 5 points as there were no differences with healthy side. Lateral compartment muscles
MRC for movement of talocrural joint scored 5 points and deep posterior compartment muscles MRC
scored 5 points for toe flexion. Sensation innervation at the peroneal and tibial nerve zones of the
foot were intact and the patient reacted to the pain using a two-point discriminatory test. Decreased
sensation was found at the lateral part of the foot and lateral malleolar side. Range of motion (ROM)
of the knee joint flexion 0–140◦ (reconstructed) and contralateral 0–145◦, ankle joint plantar flexion
0–40◦ and dorsiflexion 0–20◦ (reconstructed), and the contralateral ankle joint plantar flexion 0–45◦
and dorsiflexion 0–20◦. LEFS (Lower Extremity Functional Scale) was 92.5% as he still is not allowed
to enter the bath by himself and FAOS (Foot and Ankle Outcome Score) was 99%. The patient’s
physical development is on track with other children his age (Supplementary Video S1). There is a
great prognosis as control diagnostics have not shown any new tumors or distant masses (Figure 5).
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Ethics Approval and Consent to Participate Investigations Were Approved by the Institutional Ethical
Review Board
The study protocol was approved on 28.02.2019. by the Ethics and Scientific committee of the
Riga Stradins University Ethics committee Nr.6-3/2/47 and ICF (informed consent form) was signed by
his parents before treatment.
3. Discussion
Embryonal RMS is rare tumor with good prognostic outcome [7]. Treatment recommendations for
limb RMS combine chemotherapy and surgical tumor removal with secondary functional reconstruction
in comparison with previous recommendations consisting of radical excision, primary or secondary
amputation combined with irradiation therapy [8]. Currently, modern treatment of malignant
RMS tumors requires combined treatment: chemotherapy and radical excision with primary or
secondary reconstruction to restore functionality and improve quality of life [9,10]. Functional muscle
transplantation for oncologic patients are widely used to restore functionality of the limb in adults,
but there is paucity of articles for functional muscle transplantation at the infant age as vessel size are
extremely small [11–13].
We demonstrate a complex treatment of the embryonal RMS with one-step surgical reconstruction
with functional vastus lateralis myocutaneous microvascular flap for patient at the age of six months.
Small vessel size is challenging for microvascular anastomosis at the infant age, but refined surgical
skills and excellent magnification can lead to successful surgical outcomes. LD flap is the first choice for
the reconstruction of muscle defects due to well-known vascular anatomy, but for tumor reconstruction
cases, there is always a risk for recurrence and late limb amputation. Therefore, treatment within same
anatomical region (ipsilateral limb) minimizes the possible donor site morbidity as there is no necessity
for a functional quadriceps muscle post transfemoral amputation; however, there would be a stronger
requirement for upper extremity muscles to use crutches and to obtain better balancing when using
a prosthesis.
Functional reconstruction of triceps surae allowed the patient to start walking at age of 15 months
without noticing any differences. The two-year follow-up results showed good functional outcomes and
no signs of tumor recurrence. Maternal concern lead to prompt tumor identification, which influenced
successful treatment without radical amputation of the left lower leg.
Regular follow-up needs to occur to reduce risk of tumor recurrence for the embryonal RMS
patients using MRI or positron emission tomography (PET) scan, but to bear in mind that microvascular
flap reconstruction scar tissues or postoperative seroma can be misdiagnosed as a malignant process.
Experienced radiologists can clarify the diagnosis or surgical biopsy with histological evaluation,
which must be performed to minimize the risk of tumor recurrence.
4. Conclusions
Embryonal rhabdomyosarcoma is a rare congenital tumor with a good prognostic outcome.
We provide a successful treatment with maximal functional restoration using microvascular tissue
transplantation techniques in the infant period. We recommend the radical resection of the tumor and
functional reconstruction using microvascular flaps for pediatric patients younger than one year of age.
Supplementary Materials: The following are available online at http://www.mdpi.com/1010-660X/56/7/362/s1,
Video S1: Lower leg functionality at the two-year follow-up visit.
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